Profiling small RNAs in fecal immunochemical tests: is it possible?
Abstract Fecal microRNAs represent promising molecules with potential clinical interest as non-invasive diagnostic and prognostic biomarkers. Colorectal cancer (CRC) screening based on the fecal immunochemical test (FIT) is an effective tool for prevention of cancer development. However, due to the...
Main Authors: | Einar Birkeland, Giulio Ferrero, Barbara Pardini, Sinan U. Umu, Sonia Tarallo, Sara Bulfamante, Geir Hoff, Carlo Senore, Trine B Rounge, Alessio Naccarati |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12943-023-01869-w |
Similar Items
-
Feasibility of quantification based on novel evaluation with stool DNA and fecal immunochemical test for colorectal cancer detection
by: Hongli Xu, et al.
Published: (2022-08-01) -
Altered Fecal Small RNA Profiles in Colorectal Cancer Reflect Gut Microbiome Composition in Stool Samples
by: Sonia Tarallo, et al.
Published: (2019-10-01) -
The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
by: P. H. A. Wisse, et al.
Published: (2022-12-01) -
Evaluating gut microbiota profiles from archived fecal samples
by: Trine B. Rounge, et al.
Published: (2018-11-01) -
Fecal Immunochemical Test and Fecal Calprotectin Results Show Different Profiles in Disease Monitoring for Ulcerative Colitis
by: Sakiko Hiraoka, et al.
Published: (2018-03-01)